Jan 06, 2020
The Human Microbiome Market (3rd Edition), 2019-2030: Focus on Therapeutics (including Gut-Brain Axis Targeting Drugs), Diagnostics and Fecal Microbiota Therapies
Dec 30, 2019
Gen-Next Probiotics & Microbiome Congress: Major Breakthroughs, Challenges, and Potential Research Areas - 2-Day Event in San Diego, CA, United States - February 6-7, 2020
Oct 01, 2019
Microbiome Therapeutics Innovation Group Highlights Member Company Activity at IDWeek 2019
Sep 09, 2019
ExeGi Pharma Probiotics to be Studied in Multiple Sclerosis Patients
Jun 04, 2019
Top Medical Professionals Gather to Tackle Infant Gut Dysbiosis
May 06, 2019
Evolve BioSystems Makes Evivo Available in Hong Kong, Singapore
Jan 30, 2019
uBiome Awards Grant to North Carolina A&T State University to Study Gut Microbiome and Cardiovascular Health Risks in African-American Athletes
Nov 13, 2018
uBiome Awards Groundbreaking Grant to Investigators at NYU Winthrop Hospital to Study Gut Dysbiosis Signatures in Multiple Myeloma Patients
Oct 10, 2018
UC Davis Scientific Team Strengthens Case for Bifidobacterium in the Fight Against Antibiotic Resistance
Oct 04, 2018
Global Microbiome Therapeutics and Diagnostics Pipeline Analysis and Market Outlook to 2027 - Several Key Leading Pipeline Products will Pave the Way Forward for the Future
Sep 20, 2018
First-Ever Rapid Response Test for Levels of Bifidobacterium in Baby's Gut Microbiome
Sep 18, 2018
New Study Reveals Activated B. Infantis EVC001 Reduces Colonic Mucin Degradation in Babies
Sep 17, 2018
Global Microbiome Therapeutics & Diagnostics Market 2018-2023 - Human Therapeutic and Diagnostic Pipeline Analysis
Aug 01, 2018
Immune Advisors Publishes Peer-Reviewed Study Demonstrating Efficacy of a Probiotic and Digestive Enzymes Supplement in Protecting Against Side Effects of Cancer Chemotherapy
Jul 25, 2018
Probiotic with Digestive Enzymes Supplement Demonstrated to Reduce Cancer Chemotherapy Toxicity in Peer Reviewed Publication, according to Daily Body Restore, LLC
Jul 23, 2018
Immune Advisors Publishes Peer-Reviewed Study Demonstrating Efficacy of a Probiotic and Digestive Enzymes Supplement in Protecting Against Side Effects of Cancer Chemotherapy
Jul 18, 2018
Significant Reduction in Pathogenic Gut Bacteria Lowers Potential for Infection Risk in Infants Fed B. infantis EVC001
Jun 13, 2018
Evolve BioSystems Announces $40 Million Series C Financing to Expand its Flagship Infant Probiotic Product Evivo
Apr 17, 2018
Landmark Study To Address Global Malnutrition And Restorative Effect Of Infant Probiotic
Mar 07, 2018
New Study Shows Significant Changes to Infant Fecal pH Over Last 100 Years